Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product Liability Suits: Testosterone, Lipitor Grow While Yaz, Pradaxa Settle

Executive Summary

2014 saw some big settlements in personal injury suits involving Rx drugs, but it’s unclear whether this is a trend or just situation-specific decision-making, since fierce litigation continues for many other products.

Advertisement

Related Content

US FDA Should Regulate Ads Soliciting Mass Tort Suits, Group Says
Product Liability Litigation Playbook: Pros And Cons For Pharma
AbbVie AndroGel Jury Verdict Targets 'Low T' Promotion
Another Testosterone Warning – This Time For Abuse
Testosterone Products Need Post-Market Cardiovascular Trial
Testosterone Products Need Post-Market Cardiovascular Trial
Boehringer Avoids Pradaxa Trial, Board Chair Deposition With $650 Mil. Settlement
Pfizer Litigation Strategy: Business Focus, Legal Alliance Drive Successes
Charting The Course Of Product Liability: From Yasmin/Yaz To Actos
Product Liability Forecast: More Suits, Smaller Scale

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS056600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel